Belsomra 00006-0325
Generic: Suvorexant
Product NDC
00006-0325- Manufacturer
- Merck Sharp & Dohme Llc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- August 29, 2014
- Listing Expires
- December 31, 2026
- Application
- NDA204569
Active Ingredients
| Ingredient | Strength |
|---|---|
| Suvorexant | 15 mg/1 |
Drug Class
Orexin Receptor Antagonist [EPC]Cytochrome P450 3A Inhibitors [MoA]Orexin Receptor Antagonist [EPC]
Packaging Options(2)
1 BLISTER PACK in 1 CASE (0006-0325-13) / 3 TABLET, FILM COATED in 1 BLISTER PACK
3 CASE in 1 CARTON (0006-0325-30) / 1 BLISTER PACK in 1 CASE (0006-0325-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK